SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-167316"
 

Search: onr:"swepub:oai:DiVA.org:liu-167316" > Prominent Enhanceme...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Prominent Enhancement of Cisplatin Efficacy with Optimized Methoxy Poly(ethylene glycol)-Polycaprolactone Block Copolymeric Nanoparticles

Yen, Ying-Tzu (author)
Nanjing Univ, Peoples R China
Wang, Xinyue (author)
Nanjing Univ, Peoples R China
Zhang, Huan (author)
Linköpings universitet,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten
show more...
Wang, Chun (author)
Nanjing Univ, Peoples R China
Lin, Zitong (author)
Nanjing Univ, Peoples R China
Xie, Chen (author)
Nanjing Univ Posts and Elecommun, Ying-Tzu
Liu, Qin (author)
Nanjing Univ, Peoples R China
Wang, Lifeng (author)
Nanjing Univ, Peoples R China
Yu, Lixia (author)
Nanjing Univ, Peoples R China
Xie, Li (author)
Nanjing Univ, Peoples R China
Lv, Xin (author)
Nanjing Univ, Peoples R China
Liu, Baorui (author)
Nanjing Univ, Peoples R China
Li, Rutian (author)
Nanjing Univ, Peoples R China
show less...
 (creator_code:org_t)
AMER SCIENTIFIC PUBLISHERS, 2020
2020
English.
In: Journal of Biomedical Nanotechnology. - : AMER SCIENTIFIC PUBLISHERS. - 1550-7033 .- 1550-7041. ; 16:3, s. 335-343
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Chemotherapy has been one of the major standard treatments for a variety of cancers. cis-Dichlorodiamminoplatiunum(II) (cisplatin, CDDP), as one of the anticancer agents, demonstrated excellent efficacy against tumor and has been an indispensable component in chemotherapy, chemoradiation, chemo-molecular targeted therapy and chemo-immunotherapy. However, its therapeutic concentration was limited since its inevitable toxicity. Previously, we have constructed CDDP-loaded nanoparticles (NPs) with mixture of poly(ethyleneglycol)-polycaprolactone (PEG-PCL) and polycarprolactone (HO-PCL) by a facile method. The most optimal proportion of the two copolymers was selected through a series of physical, chemical, cytological and histological evaluations. In the present study, we explored the mechanisms of NPs and observed the in vivo antitumor effect after administrating CDDP-loaded PEG-PCL NPs. Positron emission tomography as well as computed tomography (PET/CT) were adopted for detecting tumoral metabolic activity. Images from fluorescence microscope revealed superior cellular uptake of CDDP-loaded NPs with rhodamine B aggregated intracellularly in cancer cells. Similar apoptotic rates between free CDDP group and CDDP-loaded NPs group was measured by flow cytometry. Tumor volumes and murine weights confirmed the superiority of CDDP-loaded NPs in therapeutic efficacy as compared with free CDDP. Blood tests showed milder side effects in CDDP-loaded nanoparticle group. PET/CT images illustrated less uptake intensity of FDG in mice received CDDP-loaded NPs than free CDDP. Our results suggest that PEG-PCL/PCL NPs could be a promising antitumor drug carrier for CDDP delivery with solid efficacy and minor side effects.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)

Keyword

Nanoparticles (NPs); Block Copolymer; PEG-PCL; Cisplatin (CDDP); Drug Delivery

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view